p73 is a human p53-related protein that can induce apoptosis

Nature

Volumn 389, Issue 6647, 1997, Pages 191-194

  Jost, Christine A ^a   Marin, Maria C ^a   Kaelin Jr , William G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P21; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CHLORAMPHENICOL ACETYLTRANSFERASE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DNA BINDING PROTEIN; GROWTH INHIBITOR; NUCLEAR PROTEIN; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL DEATH; CELL STRAIN BHK; CONTROLLED STUDY; DNA SEQUENCE; EMBRYO; GENE DELETION; GENE MUTATION; NEUROBLASTOMA; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR GENE; APOPTOSIS; CELL CULTURE; CELL DIVISION; CELL LINE; CHEMISTRY; CHROMOSOME 1; CHROMOSOME MAP; GENETICS; HUMAN; MOLECULAR GENETICS; PHYSIOLOGY; PLASMID; SITE DIRECTED MUTAGENESIS; TRANSACTIVATION;

APOPTOSIS; CELL DIVISION; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; GROWTH INHIBITORS; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEUROBLASTOMA; NUCLEAR PROTEINS; PLASMIDS; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0031564954     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/38298     Document Type: Article

References (25)

1. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C. C. p53 mutations in human cancers. Science 253, 49-53 (1991).
2. Levine, A. J., Momand, J. & Finlay, C. A. The p53 tumour supressor gene. Nature 351, 453-456 (1991).
3. Haffner, R. & Oren, M. p53: biochemical properties and biological effects of p53. Curr. Opin. Genet. Dev. 5, 84-90 (1995).
4. Kaghad, M. et al. Monoallelically expressed gene related to p53 at the neuroblastoma suppressor-1 locus. Cell (in the press).
5. Cho, Y., Gorina, S., Jeffrey, P. D. & Pavletich, N. P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346-355 (1994).
6. Versteeg, R. et al. 1p36: every subband a suppressor? Eur. J. Cancer 31 A, 538-541 (1995).
7. Kern, S. E. et al. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256, 827-829 (1992).
8. Diller, L. et al. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol. 10, 5772-5781 (1990).
9. Diller, L. et al. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 55, 2910-2919 (1995).
10. Pietenpol, J. A. et al. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA 91, 1998-2002 (1994).
11. Takeda, O. et al. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chrom. Cancer 10, 30-39 (1994).
12. Caron, H. et al. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nature Genet. 4, 187-191 (1993).
13. Hosoi, G. et al. Low frequency of the p53 gene mutations in neuroblastoma. Cancer 73, 3087-3093 (1994).
14. Vogan, K. et al. Absence of p53 gene mutations in primary neuroblastomas. Cancer Res. 53, 5269-5273 (1993).
15. Heald, R., McLoughlin, M. & McKeon, F. Human weel maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell 74, 463-474 (1993).
16. Chen, X., Farmer, G., Zhu, H., Prywes, R. & Prives, C. Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation. Genes Dev. 7, 1837-1849 (1993). Erratum, Genes Dev. 7, 2652 (1993).
17. Flemington, E. K., Lytle, J. P., Cayrol, C., Borras, A. M. & Speck, S. H. DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificities. Mol. Cell. Biol. 14, 3041-3052 (1994).
18. el-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
19. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. & Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249, 912-915 (1990).
20. Chen, C. & Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752 (1987).
21. Graham, F. L. & Eb, A. J. v. d. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467 (1973).
22. Chen, C. & Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752 (1987).
23. Gavrieli, Y., Sherman, Y. & Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501 (1992).
24. Sellers, W. R., Rodgers, J. W. & Kaelin, W. G. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc Natl Acad. Sci. USA 92, 11544-11548 (1995).
25. Qin, X. Q., Chittenden, T., Livingston, D. M. & Kaelin, W. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6, 953-964 (1992).